Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Hyperphagia 2Short Bowel Syndrome 1Sepsis 1Pena Shokeir syndrome, type 1 1Neoplasms 1Malnutrition 1Inflammation 1Infections 1Ileus 1Bites and Stings 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × soybean oil, phospholipid emulsion × Clear all
NCT01943409 2025-02-03

Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils

University Health Network, Toronto

Phase 4 Completed
303 enrolled 16 charts

Bites and Stings, Hyperphagia, Infections, Inflammation, Neoplasms, Sepsis, Malnutrition, Ileus

NCT04555044 2023-12-27

Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

Baxter Healthcare Corporation

Phase 4 Completed
101 enrolled 29 charts

Pena Shokeir syndrome, type 1, Hyperphagia, Short Bowel Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡